Ardsley Advisory Partners’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-15,000
| Closed | -$212K | – | 131 |
|
|
2020
Q3 | $212K | Sell |
15,000
-240,000
| -94% | -$3.39M | 0.04% | 108 |
|
|
2020
Q2 | $3.85M | Buy |
+255,000
| New | +$3.85M | 0.82% | 30 |
|
|
2019
Q3 | – | Sell |
-22,500
| Closed | -$281K | – | 132 |
|
|
2019
Q2 | $281K | Buy |
22,500
+2,500
| +13% | +$31.2K | 0.04% | 100 |
|
|
2019
Q1 | $272K | Sell |
20,000
-195,000
| -91% | -$2.65M | 0.05% | 95 |
|
|
2018
Q4 | $2.06M | Sell |
215,000
-295,000
| -58% | -$2.83M | 0.52% | 35 |
|
|
2018
Q3 | $6.17M | Buy |
510,000
+5,000
| +1% | +$60.5K | 0.83% | 31 |
|
|
2018
Q2 | $7.89M | Buy |
505,000
+70,000
| +16% | +$1.09M | 1.19% | 30 |
|
|
2018
Q1 | $6.54M | Buy |
435,000
+105,000
| +32% | +$1.58M | 0.98% | 34 |
|
|
2017
Q4 | $4.75M | Sell |
330,000
-35,000
| -10% | -$504K | 0.58% | 36 |
|
|
2017
Q3 | $5.5M | Buy |
+365,000
| New | +$5.5M | 0.73% | 40 |
|
|
2016
Q4 | – | Sell |
-225,000
| Closed | -$1.67M | – | 136 |
|
|
2016
Q3 | $1.67M | Buy |
+225,000
| New | +$1.67M | 0.26% | 56 |
|